ReviewProgress in molecular and subcellular biology2026
Inorganic Polyphosphate and Human Diseases.
Review in Progress in molecular and subcellular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The roles and synthesis of inorganic polyphosphate inbioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inorganic polyphosphate (polyP), a linear polymer of orthophosphoric acid residues, is essential for living cells from bacteria to humans. It forms complexes with metal ions, DNA, and polyhydroxybutyrate. The interaction of polyP with proteins includes polyphosphorylation at lysine and histidine residues, as well as participation in amyloid formation. The enzymes of polyP metabolism are polyfunctional, and their substrates include second messenger compounds and nucleoside phosphates. PolyP is a universal regulatory compound and plays an important role in bone tissue development, thrombosis and inflammation, signal transmission in nerve cells, carcinogenesis, and amyloid formation. PolyP participates in biofilm formation and other processes occurring during the interaction of pathogenic microorganisms with the host. PolyP of the gut microbiome is involved in maintaining intestinal functions. PolyP and the enzymes of its metabolism are promising targets for developing drugs against infections and novel approaches to treat bone, cardiovascular, and neurodegenerative diseases.
Indexed as
Identifiers
41733674What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.